Diabetic patients have less ‘hypo’s’ when using sensor
There is a significant drop in the number of ‘hypo’s’ experience among diabetes patients who, in place of a vingerprik to their blood sugar to determine, use a measuring system with a sensor.
This is evident from the global data of almost 51,000 users of the measurement device, writes the Telegraph.
The measuring system consists of a small sensor that is on the skin is worn and for which the value is to be scanned with a reader or an app on the phone.
Wednesday in Paris at a conference about new diabetestechnologie announced that in the group of patients that make use of the sensor, there is a decrease with 38 percent of hypoglycemia (low blood sugar) and a decrease with 19 percent of hyperglycemia (high blood sugar).
If the blood glucose value of a diabetic patient is low, there arises a ‘hypo’, where palpitations, fatigue, dizziness, impaired vision, altered mood, or a worse ability to concentrate may occur.
More often measure
Professor Cees Tack – head diabetes of the Radboudumc – tells the Telegraph that at first he was sceptical about the sensor. “Beforehand I thought that the blood test is more reliable than the sensor that is in the skin. But this alternative works quite well, especially because you are also much more common to measure it. It seems that if you have more monitors, you yourself as a patient can better set up (with a particular food or insulin) and you are better off,” said the professor.
According to Tack, patients are especially pleased that they no longer need to prick. “They find it a relief. No one wants to be twenty times prick a day, but it may nevertheless be necessary to check whether it is still going well. A painless scan along with your skin is of course much easier. It is, however, often to the group of patients very carefully. Those who often check, is better set. That also goes for the vingerprikken of course,” said Tack.
The Dutch Diabetes Federation is a guideline to develop when, for which patient the scanning system has a purpose. “If there is, it is likely that the device for compensation from the basic insurance eligible,” says Michiel Geldof of the Zorginstituut the Netherlands against the newspaper. In surrounding countries such as Belgium, Germany and France this is already happening.